- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-32-0005015

Berezka Pharma Private Limited
About Berezka Pharma Private Limited
Data last updated:
Berezka Pharma Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24239UP2021PTC145441.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Ritesh Srivastava and Pooja Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Ritesh Srivastava Sanskrit Mahavidyalay Ke Pas Turkmanpur Gkp, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.15 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹2.26 Lakh (net margin 2%) and EBITDA of ₹3.55 Lakh (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 88% over three years.
Berezka Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0005015).
Company details
Recognitions & Rankings of Berezka Pharma
Contact details
Berezka Pharma Private Limited's registered office is in Gorakhpur, Uttar Pradesh.
- Registered AddressC/O Ritesh Srivastava Sanskrit Mahavidyalay Ke Pas Turkmanpur Gkp, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Berezka Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Berezka Pharma Private Limited, buy the company report.
Financials of Berezka Pharma Private Limited
FY 2025 filings availableBerezka Pharma Private Limited reported revenue of ₹1.15 Cr (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 88% over three years, including 37% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.55 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.26 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.1% | |||
| Net Profit Margin | 2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Berezka Pharma Private Limited, buy the company report.
Board of directors of Berezka Pharma Private Limited
Berezka Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritesh Srivastava | Director | 21 Apr 2021 | 5 Years 6 Months | Current |
| Pooja Srivastava | Director | 21 Apr 2021 | 5 Years 6 Months | Current |
| Chhote Lal Gupta | Additional Director | 21 Oct 2021 | 5 Years 0 Months | Current |
| Sunita Gupta | Additional Director | 21 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Berezka Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Savayava Krushi Sudha Private Limited | ₹1.15 Cr (FY 2025) | -24.0% | Bangalore, Karnataka, India | |||
| Saga Innovations Private Limited | ₹1.15 Cr (FY 2025) | 58.0% | Thane, Maharashtra, India | |||
| Accurate Hydraulics Private Limited | ₹1.15 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Powercast Transdrive Private Limited | ₹1.15 Cr (FY 2025) | 15.0% | Delhi, India | |||
| Matilda Pharmaceuticals (India) Private Limited | ₹1.15 Cr (FY 2025) | 10.0% | Kankavli, Maharashtra, India | |||
| Berezka Pharma Private Limitedthis company | ₹1.15 Cr (FY 2025) | ₹2.26 Lakh | 2% | 37.0% | Gorakhpur, Uttar Pradesh, India | |
| Calcutta Spectacles Private Limited | ₹1.14 Cr (FY 2024) | 6.0% | Kolkata, West Bengal, India | |||
| Shri Narayan Mani Private Limited | ₹1.14 Cr (FY 2025) | 66.0% | Indore, Madhya Pradesh, India | |||
| Ninety 9 Infotech Private Limited | ₹1.14 Cr (FY 2024) | 2.0% | Surat, Gujarat, India | |||
| Wallasia Private Limited | ₹1.14 Cr (FY 2024) | -44.0% | New Delhi, Delhi, India | |||
| Vmedicare Private Limited | ₹1.14 Cr (FY 2024) | 295.0% | Kalyan, Maharashtra, India |
To see the full peer comparison of Berezka Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Berezka Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Berezka Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Berezka Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Berezka Pharma Private Limited has 6 board changes on record since 2021: 4 appointments and 2 cessations. The latest: Babita Mishra ceased to be Additional Director on 31 Mar 2022.
Frequently asked questions
Berezka Pharma is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 April 2021 (5+ years old) and is registered under CIN U24239UP2021PTC145441.
Berezka Pharma has 4 current directors:
- Ritesh Srivastava - Director
- Pooja Srivastava - Director
- Chhote Lal Gupta - Additional Director
- Sunita Gupta - Additional Director
The latest financial statements of Berezka Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Berezka Pharma is U24239UP2021PTC145441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Berezka Pharma was incorporated on 21 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Berezka Pharma by revenue are Savayava Krushi Sudha Private Limited, Saga Innovations Private Limited, Accurate Hydraulics Private Limited, Powercast Transdrive Private Limited, Matilda Pharmaceuticals (India) Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Babita Mishra ceased to be Additional Director on 31 Mar 2022. Ravindra Kumar Mishra ceased to be Additional Director on 31 Mar 2022. Chhote Lal Gupta was appointed as Additional Director on 21 Oct 2021. Berezka Pharma has 6 board changes on record in total.
Yes, Berezka Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0005015).
The registered office of Berezka Pharma is at CO Ritesh Srivastava Sanskrit Mahavidyalay Ke Pas Turkmanpur Gkp, Gorakhpur, Uttar Pradesh, India – 273001.
Berezka Pharma operates in the chemicals industry, in the manufacturing segment.
Berezka Pharma can be reached at its registered office: CO Ritesh Srivastava Sanskrit Mahavidyalay Ke Pas Turkmanpur Gkp, Gorakhpur, Uttar Pradesh, India – 273001.

